This content is machine translated Intracerebral hemorrhage and stroke Nursing home residents do not benefit from occupational therapy after stroke Two lectures at the 23rd European Stroke Conference in Nice were dedicated to the topic of stroke. On the one hand, it was about effective prophylaxis. How can intracerebral hemorrhage…
View Post 3 min This content is machine translated Acute stroke Is blood pressure therapy useful? Updates on the Scandinavian Candesartan Acute Stroke Trial (SCAST) were presented at this year’s European Stroke Conference in Nice. The results come in part from a long-term follow-up presented by…
View Post 4 min This content is machine translated Psoriasis and psoriatic arthritis The need for new therapeutic options is great Recently, a large multinational study investigated the impact of psoriasis and psoriatic arthritis (PsA) on the lives of people with the condition. This showed that various areas of the disease…
View Post 3 min This content is machine translated Hodgkin's lymphoma Does brentuximab vedotin have curative potential in a subset of affected individuals? New results from a phase II study presented at the ASH Congress in New Orleans offer hope for patients with refractory or relapsed Hodgkin’s lymphoma: Approximately 10% of participants in…
View Post 4 min This content is machine translated Chronic lymphocytic leukemia Not only ibrutinib attracts attention For patients with refractory or relapsed chronic lymphocytic leukemia, several agents are currently under investigation that show promising results. At the EHA Congress in Milan, the main focus was on…
View Post 3 min This content is machine translated ARUBA study Drug therapy continues to perform better A new extrapolation on the ARUBA trial shows that the benefit of simple drug therapy over intervention in patients with asymptomatic arteriovenous malformations may last much longer than originally thought.
View Post 4 min This content is machine translated Metastatic colorectal cancer Comparison between bevacizumab and cetuximab in KRAS exon2 wild type. According to preliminary results of a large phase III trial presented at this year’s ASCO congress, bevacizumab and cetuximab (combined with FOLFOX or FOLFIRI) show similar efficacy in terms of…
View Post 2 min This content is machine translated Multiple sclerosis Not all basic therapeutics are equally effective In the treatment of multiple sclerosis, various therapeutic options such as immunomodulators, immunosuppressants and monoclonal antibodies are available, but it is largely unclear how their relative mode of action is…
View Post 5 min This content is machine translated Alzheimer's disease Additional benefit in combination with cholinesterase inhibitors? As life expectancy increases, so does the number of people living with Alzheimer’s disease. A cure for this disease remains impossible, but several drugs have proven efficacy in the area…
View Post 3 min This content is machine translated PARTNER study To what extent do diabetic patients with severe aortic valve stenosis benefit from TAVI? The PARTNER trial was the first randomized trial to demonstrate that TAVI (transcatheter aortic valve implantation) is a valid alternative to surgical aortic valve replacement in patients at high surgical…
View Post 4 min This content is machine translated Breast Cancer How should action be taken without accurate study results? What is the evidence for primary tumor and metastasis in breast carcinoma? Are there treatment options that will not harm the child if a pregnant woman is found to have…
